Biopharma Daily Stock Updates - 01/22/21

$XBI $152.56 (+1.18%) 📈


COVID:

$AMPE (+16.13%) - AMPIO PHARMACEUTICALS ONGOING PHASE I CLINICAL TRIAL FOR INHALATION TREATMENT OF COVID-19 WITH AMPION IS 55% ENROLLED

https://ampiopharma.com/news/ampio-pharmaceuticals-ongoing-phase-i-clinical-trial-for-inhalation-treatment-of-covid-19-with-ampion-is-55-enrolled/


$PFE (+0.14%) & $BNTX (+2.85%) - Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19

https://biontechse.gcs-web.com/news-releases/news-release-details/pfizer-and-biontech-reach-agreement-covax-advance-purchase


$HGEN (+4.37%) - Humanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19

https://ir.humanigen.com/news/news-details/2021/Humanigen-Announces-the-Addition-of-BARDA-and-Expansion-of-CRADA-with-the-U.S.-Government-to-Develop-Lenzilumab-for-COVID-19/default.aspx


PIPELINE:

$BCRX (+0.71%) - BioCryst Announces Approval of ORLADEYO™ (berotralstat) in Japan for the Prophylactic Treatment of Hereditary Angioedema

https://ir.biocryst.com/news-releases/news-release-details/biocryst-announces-approval-orladeyotm-berotralstat-japan


$SPPI (+1.27%) - Spectrum Pharmaceuticals Announces Two Oral Presentations at Upcoming IASLC 2020 World Conference on Lung Cancer

https://investor.sppirx.com/news-releases/news-release-details/spectrum-pharmaceuticals-announces-two-oral-presentations


FINANCIAL:

$PGEN (+0.77%) - Pricing of an underwritten public offering of 15,000,000 shares of its common stock at a public offering price of $7.50 per share.

https://investors.precigen.com/news-releases/news-release-details/precigen-announces-pricing-1125-million-public-offering-common


$FULC (+0.07%) - Fulcrum Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

https://ir.fulcrumtx.com/news-releases/news-release-details/fulcrum-therapeutics-announces-closing-public-offering-common


$DBVT (-8.49%)


0 comments